{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:45:47Z","timestamp":1782953147620,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48557-5","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:24:15Z","timestamp":1777659855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association analysis of PTPN1 gene SNP with retinopathy and nephropathy in type 2 diabetes mellitus and development of predictive line graph in Chinese population"],"prefix":"10.1038","volume":"16","author":[{"given":"Qian","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"48557_CR1","unstructured":"Organization, W. H. Urgent action needed as global diabetes cases increase four-fold over past decades (World Health Organization: Geneva, Switzerland., 2024)."},{"key":"48557_CR2","unstructured":"Atlas, D. IDF Diabetes Atlas| Global Diabetes Data & Statistics. Diabetes Atlas April ;7. (2025)."},{"key":"48557_CR3","unstructured":"Magliano, D. J. & Boyko, E. J. IDF diabetes atlas. (2022)."},{"key":"48557_CR4","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. Diabetes in China part 1: epidemiology and risk factors. Lancet Public. Health (2024).","DOI":"10.1016\/S2468-2667(24)00250-0"},{"issue":"6","key":"48557_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","volume":"61","author":"RC Ma","year":"2018","unstructured":"Ma, R. C. Epidemiology of diabetes and diabetic complications in China. Diabetologia 61 (6), 1249\u20131260 (2018).","journal-title":"Diabetologia"},{"issue":"1","key":"48557_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dbi17-0013","volume":"67","author":"C Hu","year":"2018","unstructured":"Hu, C. & Jia, W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 67 (1), 3\u201311 (2018).","journal-title":"Diabetes"},{"issue":"10365","key":"48557_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"Ahmad, E., Lim, S., Lamptey, R., Webb, D. R. & Davies, M. J. Type 2 diabetes. Lancet 400 (10365), 1803\u20131820 (2022).","journal-title":"Lancet"},{"issue":"2","key":"48557_CR8","doi-asserted-by":"publisher","first-page":"018","DOI":"10.17352\/2455-8583.000042","volume":"7","author":"Y CHENG","year":"2020","unstructured":"CHENG, Y. et al. Meta-analysis of the epidemiology of microvascular complications in people with Type 2 diabetes in mainland China. Global J. Obes. Diabetes Metabolic Syndrome. 7 (2), 018\u201323 (2020).","journal-title":"Global J. Obes. Diabetes Metabolic Syndrome"},{"issue":"1","key":"48557_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2296-15-8","volume":"15","author":"K Kung","year":"2014","unstructured":"Kung, K. et al. RETRACTED ARTICLE: Prevalence of complications among Chinese diabetic patients in urban primary care clinics: a cross-sectional study. BMC Fam. Pract. 15 (1), 8 (2014).","journal-title":"BMC Fam. Pract."},{"issue":"4","key":"48557_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jdi.14149","volume":"15","author":"M Imamura","year":"2024","unstructured":"Imamura, M. & Maeda, S. Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine. J. Diabetes Invest. 15 (4), 410\u2013422 (2024).","journal-title":"J. Diabetes Invest."},{"issue":"8003","key":"48557_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","volume":"627","author":"K Suzuki","year":"2024","unstructured":"Suzuki, K. et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627 (8003), 347\u2013357 (2024).","journal-title":"Nature"},{"issue":"4","key":"48557_CR12","first-page":"95","volume":"13","author":"CMAD Society","year":"2021","unstructured":"Society, C. M. A. D. Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition). Chin. J. Diabetes. 13 (4), 95 (2021).","journal-title":"Chin. J. Diabetes"},{"issue":"8","key":"48557_CR13","first-page":"23","volume":"13","author":"Association TMCGotDSotCM","year":"2021","unstructured":"Association TMCGotDSotCM. Chinese Guidelines for the Prevention and Treatment of Diabetic Nephropathy (2021 Edition). Chin. J. Diabetes. 13 (8), 23 (2021).","journal-title":"Chin. J. Diabetes"},{"issue":"1","key":"48557_CR14","first-page":"926857","volume":"2012","author":"RC Tsou","year":"2012","unstructured":"Tsou, R. C. & Bence, K. K. The genetics of PTPN1 and obesity: insights from mouse models of tissue-specific PTP1B deficiency. J. Obes. 2012 (1), 926857 (2012).","journal-title":"J. Obes."},{"issue":"4","key":"48557_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1534-5807(02)00148-X","volume":"2","author":"JM Zabolotny","year":"2002","unstructured":"Zabolotny, J. M. et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell. 2 (4), 489\u2013495 (2002).","journal-title":"Dev. Cell"},{"key":"48557_CR16","unstructured":"Le Sommer, S., Martina, P., Martin-Granados, C. & Delibegovic, M. Protein tyrosine phosphatase 1B (PTP1B) in the immune system (Inflammation & Cell Signaling, 2015)."},{"issue":"21","key":"48557_CR17","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1128\/MCB.00959-07","volume":"27","author":"M Delibegovic","year":"2007","unstructured":"Delibegovic, M. et al. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol. Cell. Biol. 27 (21), 7727\u20137734 (2007).","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"48557_CR18","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.2337\/db09-1365","volume":"59","author":"A Fukushima","year":"2010","unstructured":"Fukushima, A. et al. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. diabetes 59 (8), 1906\u20131914 (2010).","journal-title":"diabetes"},{"issue":"3","key":"48557_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/CS20120198","volume":"124","author":"J Wada","year":"2013","unstructured":"Wada, J. & Makino, H. Inflammation and the pathogenesis of diabetic nephropathy. Clin. Sci. 124 (3), 139\u2013152 (2013).","journal-title":"Clin. Sci."},{"issue":"3","key":"48557_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","volume":"12","author":"F Wiede","year":"2022","unstructured":"Wiede, F. et al. PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity. Cancer Discov. 12 (3), 752\u2013773 (2022).","journal-title":"Cancer Discov."},{"key":"48557_CR21","doi-asserted-by":"crossref","unstructured":"Ji, Z., Luo, J., Su, T., Chen, C. & Su, Y. miR-7a targets insulin receptor substrate-2 gene and suppresses viability and invasion of cells in diabetic retinopathy mice via PI3K-Akt-VEGF pathway. Diabetes, Metabolic Syndrome and Obesity. :719\u2009\u2013\u200928. (2021).","DOI":"10.2147\/DMSO.S288482"},{"issue":"11","key":"48557_CR22","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2337\/diabetes.53.11.3013","volume":"53","author":"ND Palmer","year":"2004","unstructured":"Palmer, N. D. et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53 (11), 3013\u20133019 (2004).","journal-title":"Diabetes"},{"issue":"11","key":"48557_CR23","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.2337\/diabetes.54.11.3296","volume":"54","author":"NJ Spencer-Jones","year":"2005","unstructured":"Spencer-Jones, N. J. et al. Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 54 (11), 3296\u20133304 (2005).","journal-title":"Diabetes"},{"issue":"8","key":"48557_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm1435","volume":"12","author":"KK Bence","year":"2006","unstructured":"Bence, K. K. et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12 (8), 917\u2013924 (2006).","journal-title":"Nat. Med."},{"issue":"3","key":"48557_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2337\/db08-0913","volume":"58","author":"M Delibegovic","year":"2009","unstructured":"Delibegovic, M. et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58 (3), 590\u2013599 (2009).","journal-title":"Diabetes"},{"issue":"10","key":"48557_CR26","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/ckj\/sfad142","volume":"16","author":"S Bermejo","year":"2023","unstructured":"Bermejo, S. et al. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes. Clin. Kidney J. 16 (10), 1656\u20131663 (2023).","journal-title":"Clin. Kidney J."},{"key":"48557_CR27","doi-asserted-by":"publisher","first-page":"1265711","DOI":"10.3389\/fendo.2023.1265711","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang, J., Luo, C., Zhang, D., He, Q. & Liu, L. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study. Front. Endocrinol. 14, 1265711 (2023).","journal-title":"Front. Endocrinol."},{"issue":"11","key":"48557_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543784.2018.1538352","volume":"27","author":"JA Moreno","year":"2018","unstructured":"Moreno, J. A. et al. Targeting inflammation in diabetic nephropathy: a tale of hope. Expert Opin. Investig. Drugs. 27 (11), 917\u2013930 (2018).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"48557_CR29","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol. 14, 1149239 (2023).","journal-title":"Front. Endocrinol."},{"key":"48557_CR30","doi-asserted-by":"publisher","first-page":"583687","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester, J. V., Kuffova, L. & Delibegovic, M. The role of inflammation in diabetic retinopathy. Front. Immunol. 11, 583687 (2020).","journal-title":"Front. Immunol."},{"issue":"5","key":"48557_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang, J. & Kern, T. S. Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30 (5), 343\u2013358 (2011).","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48557-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:08:43Z","timestamp":1782950923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48557-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48557-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20270"}}